Boston Scientific Announces Agreement to Acquire Claret Medical, Inc.

Boston Scientific Corporation announced it has signed an agreement to acquire Claret Medical, Inc., a privately-held company that has developed and commercialized the Sentinel® Cerebral Embolic Protection System. The device is used to protect the brain during certain interventional procedures, predominately in patients undergoing transcatheter aortic valve replacement (TAVR). The transaction price consists of $220 million in up-front cash, as well as a potential reimbursement-based milestone payment of up to $50 million. The Sentinel System – which...

Asia Pacific Infusion Therapy Device Market Notches Strong Growth

The Asia Pacific medical device market presents immense opportunity for companies specializing in intravenous (IV) therapy equipment and consumables. Most prominently, the Chinese and Indian infusion therapy device markets grew at CAGRs of about 7% and 6%, respectively, between 2014 and 2017. Meanwhile the Australian, Japanese and South Korean markets recorded low-single digit growth. IV infusions allow direct access to the blood stream of a patient for a quick intervention. Doctors and medical personnel in the Asia Pacific region use different...

BD Acquires TVA Medical

BD (Becton, Dickinson and Company), a leading global medical technology company, announced it has completed the acquisition of TVA Medical, Inc., a company that develops minimally invasive vascular access solutions for patients with chronic kidney disease requiring hemodialysis. In the U.S. alone, there are more than 440,000 patients with End-Stage Renal Disease (ESRD) who are surviving on hemodialysis. The addition of TVA Medical enables BD to offer the everlinQ™ endoAVF System, a new endovascular arteriovenous (AV) fistula creation technology that adds to the company’s ESRD portfolio of...

Over 965,000 Angioplasties are Performed Each Year in the United States

According to the latest interventional cardiology procedural analysis by iData Research, over 965,000 angioplasties are done each year in the United States. An angioplasty, also known as percutaneous coronary intervention (PCI), is a procedure that involves stent placement to open blocked or narrowing arteries. In addition to stents, angioplasty procedures may use a number of accessories, including introducer sheaths, PTCA catheters, balloon-inflation syringes, angioplasty kits, interventional catheters and...

Integer Receives FDA Approval for Thin Wall Radial Introducer Kit, RadialSeal(TM)

Integer Holdings Corporation (“Integer”), a leading medical device outsource manufacturer, announced that it has received FDA and CE Mark approval for their new radial access introducer, RadialSeal(TM). The RadialSeal Introducer Kit is founded on Integer’s core technology platforms in guidewires and hemostatic introducers, and further strengthens its portfolio of high quality access products available for distribution by medical device companies in the interventional cardiology and peripheral vascular space. “RadialSeal was designed with...

Rapid Medical Receives CE Mark Approval for TIGERTRIEVER 13

Rapid Medical, a company focused on the development of next generation neurovascular devices, has announced that it has received CE Mark approval for the TIGERTRIEVER 13. In addition, first patients have been treated successfully with the device. TIGERTRIEVER, the first-ever adjustable, fully visible clot retriever is designed to treat ischemic stroke patients. About 1,500 patients have been successfully treated with the TIGERTRIEVER so far, the TIGERTRIEVER 13 is the newest addition of the Tigertriever family. Its default profile is 83% smaller than any other device on the market and it is delivered through a ...